Showing results (2591-2600 of 2,814) with videos related to

Sort By:
Pageof 282
Nature Communications|June 9, 2021
Molecular evidence of SARS-CoV-2 in New York before the first pandemic waveMatthew M Hernandez, Ana S Gonzalez-Reiche, Hala Alshammary, et al.
Science Translational Medicine|July 1, 2026
Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPAKeenan A Walker, Cassandra Blew, Michael R Duggan, et al.
JCI Insight|February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumorsStergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
EMBO Molecular Medicine|April 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanomaIleabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres, et al.
JAMA Network Open|August 9, 2021
Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal FluidMichael D White, Robert H Klein, Brian Shaw, et al.
JAMA Oncology|September 23, 2018
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisDaniel Y Wang, Joe-Elie Salem, Justine V Cohen, et al.
BMC Bioinformatics|April 13, 2018
Encompassing new use cases - level 3.0 of the HUPO-PSI format for molecular interactionsM Sivade Dumousseau, D Alonso-López, M Ammari, et al.
Lancet (London, England)|January 29, 2019
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 studyMartin R Gaudinski, Emily E Coates, Laura Novik, et al.
JCO Precision Oncology|August 17, 2022
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant TumorsMatthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
Pageof 282